Three versus 12‐month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta‐analysis of randomized controlled trials

Introduction The American Heart Association/American College of Cardiology guidelines on dual antiplatelet therapy (DAPT) recommend at least 12 months of a P2Y12 inhibitor and low dose aspirin in patients with an acute coronary syndrome (ACS) treated with a stent. Since that recommendation, several...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Catheterization and cardiovascular interventions 2022-12, Vol.100 (7), p.1151-1158
Hauptverfasser:	Selvaraj, Vijairam, Chatterjee, Saurav, Hirai, Taishi, Abbott, J. Dawn, Bavishi, Chirag
Format:	Artikel
Sprache:	eng
Schlagworte:	acute coronary syndrome Acute Coronary Syndrome - drug therapy Acute Coronary Syndrome - surgery Acute coronary syndromes Angioplasty Antiplatelet therapy Aspirin Bleeding Cardiovascular diseases Clinical trials DAPT Drug Therapy, Combination Duration of Therapy Hemorrhage - chemically induced Humans Implants Meta-analysis Mortality Myocardial infarction Myocardial Infarction - etiology outcomes Percutaneous Coronary Intervention - adverse effects percutaneous intervention Platelet Aggregation Inhibitors - adverse effects Randomized Controlled Trials as Topic Thrombosis Thrombosis - etiology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!